Tumor necrosis factor-α-induced activating protein-1 activity is modulated by nitric oxide-mediated protein kinase G activation

American Journal of Respiratory Cell and Molecular Biology

Volumn 22, Issue 1, 2000, Pages 105-115

  Gertzberg, Nancy ^a,b,c,d   Clements, Richard ^a,b,c,d   Jaspers, Ilona ^a,b,c,d   Ferro, Thomas J ^a,b,c,d   Neumann, Paul ^a,b,c,d   Flescher, Eliezer ^a,b,c,d   Johnson, Arnold ^a,b,c,d,e  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c STRATTON VA MEDICAL CENTER   (United States)

^d ALBANY MEDICAL COLLEGE   (United States)

^e Stratton VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BOS TAURUS; FELIS CATUS;

EID: 0034077959     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.22.1.3801     Document Type: Article

References (34)

1. 1. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from the lethal effect of endotoxin. Science 229:869-871.
2. 2. Johnson, J., B. Meyrick, G. Jesmok, and K. L. Brigham. 1989. Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in sheep. J. Appl. Physiol. 66:1448-1454.
3. 3. Tracey, K. J., S. F. Lowry, and A. Cerami. 1988. Cachectin/TNF in septic shock and septic adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138:1377-1379.
4. 4. De Caterina, R., P. Libby, K. B. Peng, V. J. Thannickal, T. B. Rajavashisth, M. A. Gimbrone, Jr., W. S. Shin, and J. K. Liao. 1995. Nitric oxide decreases cytokine-induced endothelial activation. J. Clin. Invest. 96:60-68.
5. 5. Khan, B. V., D. G. Harrison, M. T. Olbrych, R. W. Alexander, and R. M. Medford, 1996. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc. Natl. Acad. Sci. USA 93:9114-9119.
6. 6. Parry, G. C., and N. Mackman. 1995. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterisoscler. Thromb. Vasc. Biol. 15:612-621.
7. 7. Peng, H. B., T. B. Rajavashisth, P. Libby, and J. K. Liao. 1995. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J. Biol. Chem. 270: 17050-17055.
8. 8. Moncada, S., M. J. Palmer, and A. Higgs. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:109-141.
9. 9. Dixit, V. M., R. M. Marks, V. Sarma, and E. V. Prochownik. 1989. The antimitogenic action of tumor necrosis factor is associated with increased AP-1/ c-jun proto-oncogene transcription. J. Biol. Chem. 264:16905-16909.
10. 10. Abate, C., L. Patel, F. J. Rauscher III, and T. Curran. 1990. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 249:1157-1249.
11. 11. Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072:129-157.
12. 12. Ferro, T. J., N. Gertzberg, L. Selden, P. Neumann, and A. Johnson. 1997. TNF-α-induced increased endothelial permeability and oxidized p42 are mediated by nitric oxide. Am. J. Physiol. 272: L979-L988.
13. 13. Phelps, D. T., T. J. Ferro, P. J. Higgins, R. Shankar, D. M. Parker, and A. Johnson. 1995. Tumor necrosis factor-α induces the peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C activation. Am. J. Physiol. 269:L551-L559.
14. 14. Freeman, B. 1994. Free radical chemistry of nitric oxide: looking at the dark side. Chest 105:79S-84S.
15. 15. Tarpey, M. M., J. S. Beckamn, H. I. Schiropoulos, J. Z. Gore, and T. A. Brock. 1995. Peroxynitrite stimulates vascular smooth muscle cell cyclic GMP. FEBS Lett. 3:314-318.
16. 16. Gudi, T., I. Huvar, M. Meinecke, S. M. Lohman, G. R. Boss, and R. B. Pilz. 1996. Regulation of gene expression by cGMP-dependent kinase: transactivation of the cFOS promoter. J. Biol. Chem. 271:4597-4600.
17. 17. Pilz, R. B., M. Suhasini, S. Idriss, J. L. Meinkoth, and G. R. Boss. 1995. Nitric oxide and cGMP analogs activate transcription from AP-1 responsive promoters in mammalian cells. FASEB J. 9:552-558.
18. 18. Wu, H. M., Q. Huang, Y. Yuan, and H. J. Granger. 1996. VEGF induces NO-dependent hyperpermeahility in coronary venules. Am. J. Physiol. 271:H2735-H2739.
19. 19. Tabuchi, A., K. Sano, E. Oh, T. Tsuchiya, and M. Tsuda. 1994. Modulation of AP-1 activity by nitric oxide (NO) in vitro: NO-mediated modulation of AP-1. FEBS Lett. 351:123-127.
20. 20. Manna, S. K., H. J. Wang, T. Yan, L, W. Oberley, and B. B. Aggarawal. 1998. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activated protein-1. J. Biol. Chem. 273:13245-13254.
21. 21. Morris, B. J. 1995. Stimulation of immediate early gene expression in striatal neurons by nitric oxide. J. Biol. Chem. 270;24740-24744.
22. 22. Johnson, A., D. T. Phelps, and T. J. Ferro. 1994. Tumor necrosis factor-α decreases pulmonary artery endothelial nitrovasodilator by a protein kinase C-dependent mechanism. Am. J. Physiol. 267:L318-L325.
23. 23. Colbran, J. L., S. H. Francis, A. B. Leach, M. K. Thomas, H. Jiang, L. M. McAllister, and J. D. Corbin, 1992. A phenylalanine in peptide substrates provides for selectivity between cGMP-and cAMP-dependent protein kinases. J. Biol. Chem. 267:9589-9594.
24. 24. Flescher, E., J. A. Ledbetter, G. L. Schieven, N. Vela-Roch, D. Fossum, H. Dang, N. Ogawa, and N. Talal. 1994. Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. J. Immunol. 153:4880-4889.
25. 25. Luckow, B., and G. Schutz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490.
26. 26. Steel, R. G. D., and J. H. Torrie. 1980. Principles and Procedures of Statistics: A Biomedical Approach. McGraw-Hill, New York. 173-177.
27. 27. Tzeng, C. P., Y. J. Kim, R. Kumar, and A. K. Verma. 1994. Involvement of protein kinase C in the transcriptional regulation of 12-O-tetradecanoylphorbol-13-acetate inducible genes modulated by AP-1 or non-AP-1 transacting factors. Carcinogenesis 15:707-711.
28. 28. Murphy, H. S., J. A. Shayman, G. O. Till, M. Mahrougui, C. B. Owens, U. S. Ryan, and P. A. Ward. 1992. Superoxide responses of endothelial cells to C5a and TNF: divergent signal transduction pathways. Am. J. Physiol. 7: 151-159.
29. 29. Beckman, J. S., Y. Z. Ye, P. G. Anderson, J. Chen, M. A. Accavitti, M. M. Tarpey, and C. R. White. 1994. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunochemistry. Biol. Chem. Hoppe Seyler. 375:81-85.
30. 30. Maragos, C. M., D. Morley, D. A. Wink, T. M. Dunams, J. E. Saavedra, A. Hoffman, A. A. Bove, L. Issac, J. A. Hrabie, and L. K. Keefer. 1991. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide: vasorelaxants effects. J. Med. Chem. 34:3242-3247.
31. 31. Torphy, T. J. 1998. Phosphodiesterase isoenzymes. Am. J. Respir. Crit. Care Med. 157:351-370.
32. 32. Marsden, P. A., and B. J. Ballermann. 1990. Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism. J. Exp. Med. 172:1843-1852.
33. 33. Togashi, H., M. Frohman, E. Taira, R. R. Ratan, T. M. Dawson, and V. L. Dawson. 1997. Neuronal (type I) nitric oxide synthase regulates nuclear factor kappa B activity and immunologic (type II) nitric oxide synthase expression. Proc. Natl. Acad. Sci. USA 94:2676-2680.
34. 34. Matthews, J. R., C. H. Botting, M. Panico, H. R. Morris, and R. T. Hay. 1996. Inhibition of NFκB DNA binding by nitric oxide. Nucleic Acids Res. 24:2236-2242.